Series A · 2026-11-18 · AI
Boltz raises $110.0M
80
AI Score
Amount
$110.0M
Round
Series A
Lead
Bessemer Venture Partners
HQ
London, GB
Why it matters: Boltz's $110M Series A, led by Bessemer less than a year after leaving stealth, shows how quickly open-source protein-structure models are turning into funded drug-discovery platforms.
London-based AI drug discovery startup Boltz raised a $110M Series A led by Bessemer Venture Partners.
- Participants:
- Andreessen Horowitz, Amplify Partners, Zetta Venture Partners, Obvious Ventures, Greycroft, F-Prime Capital, Hummingbird, Benchling, Nvidia
- Source:
- Tech.eu ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for Boltz
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
More deals with Bessemer Venture Partners
Recent AI rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing